Citations (20)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Ashley Brenton, Steven Richeimer, Maneesh Sharma, Chee Lee, Svetlana Kantorovich, John Blanchard & Brian Meshkin. (2017) Observational study to calculate addictive risk to opioids: a validation study of a predictive algorithm to evaluate opioid use disorder. Pharmacogenomics and Personalized Medicine 10, pages 187-195.
Read now
Read now
Melanie E. Bennett, Kristen R. Bradshaw & Lauren T. Catalano. (2017) Treatment of substance use disorders in schizophrenia. The American Journal of Drug and Alcohol Abuse 43:4, pages 377-390.
Read now
Read now
Manuel Sutter$suffix/text()$suffix/text(), Marc Walter, Kenneth M. Dürsteler, Johannes Strasser & Marc Vogel. (2017) Psychosis After Switch in Opioid Maintenance Agonist and Risperidone-Induced Pisa Syndrome: Two Critical Incidents in Dual Diagnosis Treatment. Journal of Dual Diagnosis 13:2, pages 157-165.
Read now
Read now
Jana Ruda-Kucerova, Zuzana Babinska, Petra Amchova, Tibor Stark, Filippo Drago, Alexandra Sulcova & Vincenzo Micale. (2017) Reactivity to addictive drugs in the methylazoxymethanol (MAM) model of schizophrenia in male and female rats. The World Journal of Biological Psychiatry 18:2, pages 129-142.
Read now
Read now
Articles from other publishers (16)
Allison J. OberSarah B. HunterColleen M. McCulloughIsabel LeamonMichael McCrearyIvan BeasAlanna MonteroDerjung M. TarnElizabeth BromleyBrian HurleyJohn SheeheJeremy MartinezKatherine E. Watkins. (2022) Opioid Use Disorder Among Clients of Community Mental Health Clinics: Prevalence, Characteristics, and Treatment Willingness. Psychiatric Services 73:3, pages 271-279.
Crossref
Crossref
Kirsten Catthoor & Geert Dom. 2022. Psychosis and Personality Disorders. Psychosis and Personality Disorders
57
73
.
Lisa S. Meredith, Miriam S. Komaromy, Matthew Cefalu, Cristina Murray-Krezan, Kimberly Page, Karen Chan Osilla, Alex R. Dopp, Isabel Leamon, Lina Tarhuni, Grace Hindmarch, Vanessa Jacobsohn & Katherine E. Watkins. (2021) Design of CLARO (Collaboration Leading to Addiction Treatment and Recovery from other Stresses): A randomized trial of collaborative care for opioid use disorder and co-occurring depression and/or posttraumatic stress disorder. Contemporary Clinical Trials 104, pages 106354.
Crossref
Crossref
Kathleen T. Brady, Frances R. Levin, Marc Galanter & Herbert D. KleberElizabeth Schwartz, Mary Brunette & Alan Green. 2021. The American Psychiatric Association Publishing Textbook of Substance Use Disorder Treatment. The American Psychiatric Association Publishing Textbook of Substance Use Disorder Treatment.
Kevin J. Li, Anderson Chen & Lynn E. DeLisi. (2020) Opioid use and schizophrenia. Current Opinion in Psychiatry 33:3, pages 219-224.
Crossref
Crossref
Kristiina Kivimies, Eila Repo-Tiihonen, Hannu Kautiainen & Jari Tiihonen. (2018) Comorbid opioid use is undertreated among forensic patients with schizophrenia. Substance Abuse Treatment, Prevention, and Policy 13:1.
Crossref
Crossref
Stanislav Spivak, Bernadette Cullen, William Eaton, Katie Nugent, Amethyst Spivak, Ashley Fenton, Katrina Rodriguez & Ramin Mojtabai. (2018) Prescription opioid use among individuals with serious mental illness. Psychiatry Research 267, pages 85-87.
Crossref
Crossref
Joshua Chiappelli, Shuo Chen, Ann Hackman & L. Elliot Hong. (2018) Evidence for differential opioid use disorder in schizophrenia in an addiction treatment population. Schizophrenia Research 194, pages 26-31.
Crossref
Crossref
Chee Lee, Maneesh Sharma, Svetlana Kantorovich & Ashley Brenton. (2018) A Predictive Algorithm to Detect Opioid Use Disorder. Health Services Research and Managerial Epidemiology 5, pages 233339281774746.
Crossref
Crossref
Jana Ruda-Kucerova, Zuzana Babinska, Tibor Stark & Vincenzo Micale. (2017) Suppression of Methamphetamine Self-Administration by Ketamine Pre-treatment Is Absent in the Methylazoxymethanol (MAM) Rat Model of Schizophrenia. Neurotoxicity Research 32:1, pages 121-133.
Crossref
Crossref
Lynn E. DeLisi & W. Wolfgang Fleischhacker. (2017) Schizophrenia and substance abuse. Current Opinion in Psychiatry 30:3, pages 169-170.
Crossref
Crossref
Maneesh Sharma, Chee Lee, Svetlana Kantorovich, Maria Tedtaotao, Gregory A. Smith & Ashley Brenton. (2017) Validation Study of a Predictive Algorithm to Evaluate Opioid Use Disorder in a Primary Care Setting. Health Services Research and Managerial Epidemiology 4, pages 233339281771741.
Crossref
Crossref
Laurence Lalanne, Luisa Weiner & Gilles Bertschy. 2017. Handbook of Treatments for Autism Spectrum Disorder. Handbook of Treatments for Autism Spectrum Disorder
377
395
.
Deborah A. Salani, Martin Zdanowicz & Laly Joseph. (2016) Heroin use. Journal of Psychosocial Nursing and Mental Health Services 54:6, pages 30-37.
Crossref
Crossref
Laurence Lalanne, Pierre-Eric Lutz, Benoit Trojak, Jean-Philippe Lang, Brigitte L. Kieffer & Elisabeth Bacon. (2016) Medications between psychiatric and addictive disorders. Progress in Neuro-Psychopharmacology and Biological Psychiatry 65, pages 215-223.
Crossref
Crossref
Sarah C. Akerman, Mary F. Brunette, Douglas L. Noordsy & Alan I. Green. (2014) Pharmacotherapy of Co-Occurring Schizophrenia and Substance Use Disorders. Current Addiction Reports 1:4, pages 251-260.
Crossref
Crossref